You are here

  • Home
  • Archive
  • Volume 74, Issue 12
  • Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Article metrics

Article menu
Download PDFPDF
Letter
Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: September 2015 to March 2024

AbstractFullPdf
Sep 2015530141243
Oct 2015371832
Nov 201519551177
Dec 2015852785
Jan 2016621923
Feb 2016422233
Mar 2016301924
Apr 2016581722
May 2016302019
Jun 2016301721
Jul 201623108
Aug 201622108
Sep 201616810
Oct 201623136
Nov 20161395
Dec 20161485
Jan 2017251013
Feb 201725147
Mar 2017321715
Apr 201734106
May 201729107
Jun 20173142
Jul 20175954
Aug 20174852
Sep 20174342
Oct 201756106
Nov 20175686
Dec 20171733
Jan 20188144
Feb 20181622
Mar 20183110
Apr 20184365
May 20184855
Jun 20184943
Jul 20184455
Aug 20183352
Sep 20182952
Oct 20182555
Nov 20183400
Dec 20185233
Jan 20194775
Feb 20194443
Mar 20194064
Apr 20193632
May 20192511
Jun 20193352
Jul 20194464
Aug 20195762
Sep 20193312
Oct 20195232
Nov 20193765
Dec 20192641
Jan 20205522
Feb 20205272
Mar 20203740
Apr 20204630
May 20203221
Jun 20203221
Jul 20205051
Aug 20203500
Sep 20206333
Oct 20204421
Nov 20202531
Dec 20202400
Jan 20214041
Feb 20213922
Mar 20213310
Apr 20211911
May 20211000
Jun 2021221
Jul 2021111
Aug 2021332
Sep 2021421
Oct 20215100
Nov 20214710
Dec 20215611
Jan 20225661
Feb 20224310
Mar 20226010
Apr 20224400
May 20228821
Jun 20227710
Jul 20225210
Aug 20226732
Sep 20228341
Oct 20228721
Nov 20226042
Dec 20224910
Jan 20235221
Feb 20237811
Mar 202317610
Apr 20231359
May 20232411
Jun 20233000
Jul 20231431
Aug 20234651
Sep 2023400
Oct 20231331
Nov 202371115
Dec 20233010
Jan 20243143
Feb 20244170
Mar 20243321
Total4687734927